A mesothelioma prognostic model from medical machine learning firm Owkin has been showcased in the journal Nature, and is being used to help further drug research into the often fatal disea
Many healthcare companies still don’t see digital health companies as viable partners despite recent progress in the industry, according to a new survey.
Spain’s Ferrer has begun a new digital health collaboration programme, inviting start-ups to respond to three challenges in care for patients with chronic diseases, adherence to medication
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
